Kazem Rahimi, a Professor of Cardiovascular Medicine at the University of Oxford, delves into the critical landscape of blood pressure management in type 2 diabetes. The conversation highlights the urgent need for updated guidelines due to the common overlap of hypertension and diabetes. They discuss the importance of lifestyle adjustments alongside pharmacological strategies, emphasizing ACE inhibitors and ARBs. Recent advancements, like SGLT2 inhibitors, are showcased for their cardiac and renal benefits, offering a fresh perspective on comprehensive diabetes care.